adaptive DBS delivered through AlphaDBS IPG System for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Mar 2022: Trial registered, NCT05262348
  2. 12 Aug 2024: Trial withdrawn, NCT05262348

The trials

NCT05262348: An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation

State
Withdrawn before it started
Phase
No phase
People
0 taking part
Started
Aug 2022
Primary completion
30 Aug 2024
Arms
Phase 1b - adaptive stimulation
Results
None posted
  1. 2 Mar 2022: Trial registered
  2. 12 Aug 2024: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.